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ABSTRACT  Neutrophils play a crucial role in host defense against microbial infections. 
During phagocytosis of invading bacteria or fungi, the phagocyte NADPH oxidase produces 
superoxide. The importance of the oxidase is exemplified by the genetic disorder known as 
chronic granulomatous disease (CGD). The neutrophils of CGD patients cannot produce 
superoxide, with the result that affected infants and children suffer from severe recurrent 
bacterial and fungal infections. Staphylococcus aureus and Aspergillus fumigatus often cause 
life-threatening infections in these patients. The phagocyte NADPH oxidase is composed of 
the plasma membrane protein (cytochrome b558) and cytosolic proteins. Cytochrome b558 is a 
heterodimer consisting of the gp91phox and p22phox. The cytosolic proteins are p47phox, p67phox, 
p40phox and a small G-protein, Rac. The oxidase is also expressed in peripheral eosinophils, 
monocytes, B lymphocytes, and several cultured cell lines after differentiation other than 
neutrophils. Here, we will consider and discuss the oxidase in relation to CGD.
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A GENERAL VIEW OF BIODEFENSE
   Skin, epithelia and mucosa that cover the 
human body, as well as respiratory and digestive 
organs are the primary shield against invading 
microorganisms. The surface cells are moving 
up and falling down according to their fate with 
incessant proliferation, which is the first defense 
to prevent infections1). When pathogenic agents 
penetrate the surface barrier, neutrophils are in 
the front line in defense against these agents. It is 
generally known that the full of meshes by blood 
vessel does not overlook the invaders and facilitates 
a swift attack by the phagocytes2). The most 
important function of neutrophils is containment 
of unwished visitors. The number of neutrophils is 
normally around 5,000 cells/µl. During bacterial 
infections, the number often rises to >10,000 cells. 
The rapid increase in neutrophils is considered 
to be one of the basic defense mechanism. When 
the number of neutrophils falls below 500 cells/
µl, the risk of infectious diseases increases, 
as shown in patients with leukopenia, such as 
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aplastic anemia, myelodysplastic syndrome and 
leukemia3). Monocytes/Macrophages reach areas of 
inflammation and cooperate with neutrophils in the 
fight against microorganisms. Antigen-presenting 
macrophages as well as B cells indicate the presence 
of invading organisms to T cells, via MHC-class-
2-containing peptides derived from the digested 
microorganisms in the cells. Antigen-specific T 
cells increase their own activities and also induce 
antigen-specific B cells to secrete antibodies4). 
Ligand recognition sites and Fc portions contained 
in antibodies form a strong connection between the 
microorganisms and phagocytes, that is to say, the 
binding capability of the phagocytes to the antigens 
increases. Similarly, Complement system works as 
opsonization. Thus, white blood cells and serum 
coordinately eliminate invading microorganisms.
BACTERIAL KILLING BY NEUTROPHILS
   Neutrophils as professional phagocytes play 
a crucial role in host defense against microbial 
infections. During phagocytosis of invading 
microorganisms or upon cell stimulation with the 
bacterium-derived peptide, formyl-methionyl-
leucyl-phenylalanine (fMLP), phagocytes produce 
superoxide which is a precursor of microbicidal 
reactive oxygen species (ROS) by catalysis of 
activated phagocyte NADPH oxidase5). ROS derived 
from superoxide are essential for microbial killing. 
The importance of the phagocyte NADPH oxidase is 
underlined by the genetic disorder known as chronic 
granulomatous disease (CGD). The neutrophils of 
CGD patients do not produce superoxide, with the 
result that affected infants and children suffer from 
severe recurrent bacterial and fungal infections6). 
CGD was first reported in 1957 and was considered 
a rare genetic disease7). However, nowadays, there 
is approximately 1 case in 200,000 children in 
the USA, Europe and Japan. Neutrophils of some 
patients produce a little superoxide, but the relation 
between the quantity produced and the symptoms 
remained unclear until these days. Neutrophils 
also have a large number of defensive peptides, 
such as cathepsin, lysozyme and defensin in their 
granules. The peptides perform bacteriolysis after 
fusion to phagosomes containing bacteria1). After 
phagocytosis, the invaders are broken into pieces 
by ROS and the defensive peptides, together with 
several proteases.
   It is well known that defective function of 
neutrophils leads to infectious disease. Membrane-
bound integrin-family is necessary for neutrophils 
to adhere to the vessel wall and migrate to the site 
of inflammation. CD18, one of the heterodimers 
comprising β2 integrin, is defective in leukocyte 
adhesion deficiency (LAD)8,9). During a rolling 
in blood vessel, at first, neutrophils contact to the 
endothelial cells by way of sialic acid-dependent 
weak attachment. As a next step for extravasation, 
lymphocyte function associated antigen-1 (LFA-
1; a heterodimer of CD18/CD11a), which is 
expressed by neutrophils, is necessary for strong 
adhesion to the vascular endothelial cells (Fig. 1). 
The counterpart of LFA-1 is intercellular adhesion 
molecule-1 (ICAM-1; CD54), which is expressed 
on the activated endothelial cells covering the inside 
of the blood vessel. Neutrophils of LAD patients do 
not undergo extravasation due to the lack of LFA-
1. These neutrophils are also devoid of complement 
Fig. 1.　Scanning electron micrograph of neutrophils is 
imaged at ×3,000 magnification. Scale bar represents 10 µm. 
Neutrophils are incubated at 37℃ for 30 min over slide glass.
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Fig. 2.　(a) Molecular oxygen is used for respiration in our 
daily life to extract energy. (b) Superoxide (O2
-) is converted 
to hydrogen peroxide (H2O2) with or without enzyme, SOD. 
(c) Hydrogen peroxide is broken down by catalase into 
water and oxygen. (d) Hydrogen peroxide is converted to 
hypochlorous acid (OCl-) in the phagosomes.
receptor, CR3 constituted with CD18 and CD11b. 
Thus, the patients have defective activity of 
phagocytosis against opsonized bacteria in their 
neutrophils. 
   Both chemotaxis and bacterial killing activity by 
neutrophils are also disturbed in case of Chediak–
Higashi syndrome, with sustained life-threatening 
infections caused by dysfunctions in lysosome-
related organelle biogenesis. In other words, the 
defensive importance of neutrophils is highlighted 
by these hereditary diseases10).
REACTIVE OXYGEN SPECIES (ROS)
   Molecular oxygen is transported by red blood 
cells for respiration in daily life. The ultimate 
objective of respiration is to produce energy by 
aerobic metabolism within cells (Fig. 2a). Oxygen is 
also used by white blood cells as a defense purpose, 
which is the main theme of this article. Superoxide 
(O2
- : superoxide anion) produced by the phagocyte 
NADPH oxidase is reduced by dismutation itself 
or catalyzed by superoxide dismutase (SOD) (Fig. 
2b). Catalase catalyzes toxic hydrogen peroxide 
(H2O2) to water and oxygen (Fig. 2c). Thus, non-
catalase producing bacteria such as Streptococcus 
pyogenes are not likely to become major infectious 
agents in CGD because they are killed by their own 
ROS in phagosomes. However, catalase-producing 
bacteria such as Staphylococcus aureus and the 
fungus Aspergillus fumigatus cause life-threatening 
infections in CGD patients6).
   When we observe molecular oxygen structurally, 
it requires electrons to become a stable structure 
inevitably. It is a fate of oxygen to remove electrons 
from other atoms. Namely, oxygen facilitates 
oxidation for a partner of a chemical compound. 
Molecular oxygen is converted to water after 
reduction by four electrons. Thus, water is stable 
and may also be called inactive oxygen. Hydrogen 
peroxide is produced from superoxide, and hydroxy 
radical (･OH) is produced from hydrogen peroxide 
together with a reduced form of iron or superoxide. 
Superoxide itself is not thought to be too toxic 
for bacteria, but these derivatives act as strong 
disinfectants.
THE PHAGOCYTE NADPH OXIDASE
   It was well known that neutrophils consume 
oxygen abruptly just  after  phagocytosis of 
bacteria11). NADPH but not NADH is oxidized 
to transfer electrons from inside to outside of 
the plasma membrane at the same time with the 
consumption of oxygen12). NADH is not used by 
the oxidase at the physiological concentration in 
the cytosol because of the low affinity with the 
oxidase. NADPH is produced by way of pentose 
phosphate pathway from glucose, and historically, 
the oxidase was thought to be a simple enzyme 
that donated electrons to molecular oxygen. 
This enzyme is now believed to be a complex 
constituted by six proteins13). The consumption 
of oxygen accompanied with phagocytosis is 
not disturbed by cyanide, which disrupts the 
electron transport chain in mitochondria. It was 
found in the 1960s that stimulation of neutrophils 
leads to production of hydrogen peroxide and, 
in the 1970s, that superoxide is produced by 
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the same stimulation. The acidic conditions in 
the phagosomes with a large number of protons 
are ideal for superoxide to convert to hydrogen 
peroxide (Fig. 2b). Furthermore, myeloperoxidase 
(MPO) released from azurophilic granules after 
the fusion with phagosomes changes hydrogen 
peroxide to hypochlorous acid (HClO) (Fig. 2d). It 
is noteworthy that we are using hydrogen peroxide 
and hypochlorous acid as disinfectants on a daily 
basis and that our neutrophils are also utilizing 
the same agents in our body. MPO is present in 
large quantities and occupies >3% of all protein 
in neutrophils. Therefore, hypochlorous acid is 
produced more than hydroxy radicals in phagosomes 
under physiological conditions.
   The phagocyte NADPH oxidase is composed of 
a membrane-spanning glycoprotein, cytochrome 
b558 and cytosolic proteins, p47
phox, p67phox, p40phox 
(phox: phagocyte oxidase), and a small G-protein, 
Rac13,14). Cytochrome b558 is a heterodimeric protein 
composed of gp91phox (the 91-kDa glycoprotein) 
and p22phox.  Superoxide is produced by the 
active phagocyte NADPH oxidase of peripheral 
neutrophils, eosinophils, and monocytes15). In 
the 1990s, we found the oxidase in peripheral B 
lymphocytes and some B cell lines16,17). However, 
the exact function in B cells remains to be 
established. Obvious disorders of acquired immunity 
in CGD have not been clarified as yet, although 
hyper-γglobulinemia is sometimes present in 
the disease. Activation of the oxidase is strictly 
restricted because of its toxicity for humans as well 
as bacteria. When the phagocytes are stimulated, 
cytochrome b558 forms a complex with cytosolic 
proteins and is activated to produce superoxide 
(Fig. 3). p67phox directly binds to p47phox between 
the C-terminal src homology 3 (SH3) domain and 
the proline-rich region (PRR), respectively. p67phox 
also directly binds to p40phox via interaction between 
these PB1 domains. In the resting state, two SH3 
Fig. 3.　Protein-protein interactions of the active phagocyte NADPH oxidase. p67phox contains a domain 
containing four units of TPR (tetratricopeptide repeat), PB1 domain (Phox and Bem1 domain) and SH3 
domain. p47phox contains two SH3 domains (src homology 3 domain) in the center and the C-terminal PRR 
(proline-rich region). p40phox harbors PB1 domain.
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domains in p47phox are masked by itself and don’t 
bind to PRR in p22 phox.  When the cells  are 
stimulated, p47phox binds to PRR, which means 
translocation of cytosolic proteins to the plasma 
membrane. GTP-bound active Rac binds to TPR of 
p67phox and anchors to plasma membrane with lipid 
attached to CAAX box in the C-terminus. The gene 
encoding gp91phox (CYBB) alone is located on the 
X-chromosomes, and thus most of the patients are 
boys6). In the case of gp91phox deficiency, expression 
level of p22phox is also diminished, and the gp91phox 
protein is hardly detected when the cause of CGD 
is loss of p22phox. Gp91phox harbors binding sites 
of heme, NADPH and FAD (Fig. 3)18). Thus, 
cytochrome b558 is thought to possess the core of 
the electron transport system. Indeed, the purified 
cytochrome b558 is sufficient for the production 
of superoxide when the protein is surrounded by 
certain lipid conditions19).
DETECTION OF SUPEROXIDE AND DIAGNOSIS
   Superoxide produced by neutrophils is detected 
by cytochrome c reduction (Fig. 4), nitro blue 
tetrazolium reduction, or calculated from cyanide-
insensitive oxygen consumption5. 11-13). With the 
development of probes and machines to detect ROS 
by chemiluminescence (CL), this method has been 
used widely13. 15). CL with Lucigenin, one of the 
most sensitive probes to detect superoxide, is also 
dependent on the extent of adhesion by neutrophils, 
and therefore, reflects activities for both the 
phagocyte NADPH oxidase and cell adhesion20). 
Thus, Lucigenin-enhanced CL using a mixture of 
adhering and non-adhering cells in a conventional 
tube is adopted for screening both CGD and LAD. 
Either Luminol or Diogenes, other CL probes, can 
be used to avoid the effect by cell adhesion. A mix 
of the CL probes, Luminol and Diogenes, detects 
ROS more quantitatively and with higher sensitive 
than each probe alone, as well as Lucigenin20). 
Fig. 4.　Oxidized cytochrome c (Fe3+) does not show absorbance at 550 nm. However, reduced form (Fe2+) after receiving 
electron from superoxide absorbs light at the wave-length. Note that 540 nm is a specific wavelength where both reduced 
and oxidized cytochrome c indicate the same absorbance.
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Recently, the fluorescent probe dihydrorhodamine 
123 (DHR) has been widely used in flow-cytometry 
to  quant i fy  ROS produced by phagocytes . 
Superoxide produced outside the plasma membrane 
by the phagocyte NADPH oxidase is changed to 
hydrogen peroxide which in turn, passes through 
the membrane into the cytosol and oxidizes DHR. 
Oxidized DHR emits fluorescence around 525 nm 
by absorbing the energy of excitation at 488 nm3. 21).
NEW INSIGHTS
Basic progress: 
   The transcriptional regulation of gp91phox has 
been characterized in the past 15 years after it was 
discovered that CGD has a mutation in the promoter 
region of the gene. PU.1 is a key transcription factor 
for the expression of the gp91phox gene in neutrophils 
but not in eosinophils15. 22). 
   In 2011, we clarified epigenetic regulation of 
gp91phox by GCN5, one of the most important 
histone acetyltransferase. GCN5-deficiency causes 
loss of activity to produce superoxide by repressing 
transcription of the gp91phox gene. Chromatin 
immunoprecipitation assay reveals that both 
the association of GCN5 with the gp91phox gene 
promoter and elevated acetylation levels of histones 
(H2B, Lys16 and H3, Lys9) around the promoter are 
important for the expression of gp91phox 23).
   Symptoms of CGD: Although CGD patients are 
susceptible to infections, the extent of the damage 
is diverse. Some patients do not have severe 
symptoms, and thus, a longer time is required 
for a definite diagnosis can be made. We have 
been thinking that patients with modest residual 
production of ROS in neutrophils have significantly 
less severe illness than those without any such 
production. In 2011, a study of 287 patients showed 
clearly that higher residual production of ROS is 
a predictor of longer survival21). The method for 
detection of ROS was based on DHR.
   Patients with Mendelian susceptibility to 
mycobacter ia l  d iseases  (MSMD),  who are 
vulnerable to weakly virulent mycobacterial species 
as well as Mycobacterium tuberculosis, have a 
mutation in either of six genes (IFNGR1, IFNGR2, 
STAT1, IL12B, IL12BR1, and IKBKG), which 
results in impaired IL-12/23-IFN-γ-mediated 
signals24). However, the location of this genetic 
disorder has not been found in half of the MSMD 
patients. In 2011, it was reported that two relatives 
developed X-linked recessive MSMD, and each 
had a mutation leading to amino acid substitution 
(Thr178Phe or Gln231Phe) in gp91phox, which 
has not previously been found in CGD patients. 
MSMD patients suffer from recurrent tuberculous 
mycobacterial disease and have impaired oxidase 
activity in monocyte-derived macrophages but not 
in monocytes or neutrophils25).
   Treatment for CGD: Bone marrow transplantation 
(BMT) still seems to be difficult for CGD patients 
because of the distinguish characteristics of the 
diseases, susceptible to infections. However, the 
conditioning regimens, including pretreatment 
according to the donor, certainly increase the 
success rate for BMT. BMT with infectious 
conditions found in several lymph nodes has been 
sometimes carried in CGD patients26. 27). Adenosine 
deaminase deficiency, X-linked severe combined 
immunodeficiency, Wiskott-Aldrich syndrome 
and CGD are the main targets for gene therapy 
with retroviral or lentiviral-vectors. Pretreatment 
with busulfan seems to be effective though 
myelodysplastic syndrome may be caused by some 
of the vectors28). It is still difficult to establish 
long-term effectiveness because of gene silencing 
of the introduced gp91phox. This method seems 
to give us an assignment as to an improvement 
toward a prolonged and stable oxidase expression 
in neutrophils in patients with CGD. A transient 
recovery from infections, however, is hopefully 
possible.
   Thalidomide was used as a sedative in West 
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Germany in  1957  and  Japan in  1958 ,  and 
malformations were reported in 1959. In the mid-
1960s, its validity for multiple myeloma was 
confirmed, and the drug has been used in Japan 
since 2008 with sever restrictions. Thalidomide is 
thought to be suppressive of chronic inflammation, 
therefore, its future application for CGD might be 
possible29. 30).
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